Skip to main content

Table 3 A comparison, among metformin users, of clinical characteristics between survivors and nonsurvivors

From: Lactic acidosis and severe septic shock in metformin users: a cohort study

Variable Survivors Nonsurvivors
N = 19 n = 25 p
pH (mean ± SD) 7.06 ± 0.29 7.05 ± 0.16 0.93
Bicarbonate (mEq/L) (mean ± SD) 11.6 ± 6.4 10.4 ± 5.2 0.52
APACHE II (mean ± SD) 16.0 ± 6.1 28.8 ± 8.2 0.006
Morscore* (median, range) 22.0 (9.7–34.5) 59.6 (37.7–78.9) 0.01
Creatinine* (md/dL) (median, range) 1.65 (1.29–5.08) 1.95 (1.50–2.88) 0.73
Pread cre* (mg/dL) (median, range) 0.85 (0.66–1.70) 0.87 (0.70–1.15) 0.83
Anion gap (mean ± SD) 30.4 ± 10.0 28.1 ± 8.6 0.46
HD** (%) 52.6 28.0 0.028
Body temperature (°C) (mean ± SD) 36.2 ± 1.5 36.0 ± 1.0 0.67
  1. Data are represented as means ± standard deviations (SD), medians and ranges, or percentages
  2. APACHE II acute physiology and chronic health evaluation II, Morscore mortality score, based on APACHE II score, Pread cre preadmission creatinine, HD hemodialysis
  3. p for t test, *Mann–Whitney or **chi-square